- Oct 11, 2018
- 1,159
- 1,025
U.S. Special Operations Command (SOCOM), the organization that administers America’s Spec Ops forces, says it will soon start clinical trials of an “anti-aging pill” that could halt some naturally degenerative effects of aging.
“We have completed pre-clinical safety and dosing studies in anticipation of follow-on performance testing in fiscal year 2022,” Navy Commander Tim Hawkins, a SOCOM spokesperson, told Breaking Defense.
The pill involves what Hawkins called a “human performance small molecule” that will be fashioned into a nutraceutical form for both civilians and military personnel. He continued:
Full article: https://www.popularmechanics.com/sc...g-pill/?utm_source=pocket-newtab-global-en-GB
“We have completed pre-clinical safety and dosing studies in anticipation of follow-on performance testing in fiscal year 2022,” Navy Commander Tim Hawkins, a SOCOM spokesperson, told Breaking Defense.
The pill involves what Hawkins called a “human performance small molecule” that will be fashioned into a nutraceutical form for both civilians and military personnel. He continued:
“These efforts are not about creating physical traits that don’t already exist naturally. This is about enhancing the mission readiness of our forces by improving performance characteristics that typically decline with age. Essentially, we are working with leading industry partners and clinical research institutions to develop a nutraceutical, in the form of a pill that is suitable for a variety of uses by both civilians and military members, whose resulting benefits may include improved human performance—like increased endurance and faster recovery from injury.”
Full article: https://www.popularmechanics.com/sc...g-pill/?utm_source=pocket-newtab-global-en-GB